Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-22 4:06 pm Purchase | 2024-02-20 | 13D | FREELINE THERAPEUTICS HLDGS FRLN | Syncona Portfolio Ltd | 65,872,764 100.000% | 28,010,632 (+73.98%) | Filing History |
| 2024-02-14 12:15 pm Sale | 2023-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Eventide Asset Management, LLC | 0 0.000% | -394,718 (Position Closed) | Filing History |
| 2024-02-12 4:24 pm Sale | 2023-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Integrated Core Strategies (US) LLC | 0 0.000% | -5,555,085 (Position Closed) | Filing History |
| 2024-01-31 4:10 pm Purchase | 2023-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Tetragon Financial Group Limited | 6,375,000 9.800% | 6,108,333 (+2290.62%) | Filing History |
| 2023-11-24 07:30 am Unchanged | 2023-11-22 | 13D | FREELINE THERAPEUTICS HLDGS FRLN | Syncona Portfolio Ltd | 37,862,132 57.900% | 0 (Unchanged) | Filing History |
| 2023-10-18 06:04 am Purchase | 2023-10-17 | 13D | FREELINE THERAPEUTICS HLDGS FRLN | Syncona Portfolio Ltd | 37,862,132 57.920% | 35,337,989 (+1400.00%) | Filing History |
| 2023-07-17 4:50 pm Purchase | 2023-07-12 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Integrated Core Strategies (US) LLC | 5,555,085 8.500% | 5,555,085 (New Position) | Filing History |
| 2023-02-14 1:54 pm Purchase | 2022-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Eventide Asset Management, LLC | 394,718 9.100% | 162,341 (+69.86%) | Filing History |
| 2023-02-13 12:01 pm Purchase | 2022-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | CHI Advisors LLC | 320,961 7.410% | 195,868 (+156.58%) | Filing History |
| 2023-01-31 4:15 pm Purchase | 2022-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Tetragon Financial Group Limited | 266,667 6.200% | 20,000 (+8.11%) | Filing History |
| 2022-03-25 4:07 pm Purchase | 2022-03-15 | 13D | FREELINE THERAPEUTICS HLDGS FRLN | Syncona Portfolio Ltd | 2,524,143 62.270% | 1,269,841 (+101.24%) | Filing History |
| 2022-03-21 11:10 am Purchase | 2022-03-10 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Tetragon Financial Group Limited | 246,667 6.100% | 246,667 (New Position) | Filing History |
| 2022-02-14 11:47 am Purchase | 2021-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Eventide Asset Management, LLC | 232,377 9.700% | 66,667 (+40.23%) | Filing History |
| 2022-02-11 1:00 pm Purchase | 2021-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | CHI Advisors LLC | 125,093 5.240% | 125,093 (New Position) | Filing History |
| 2022-02-11 12:20 pm Unchanged | 2021-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Syncona Portfolio Ltd | 1,254,302 52.500% | 0 (Unchanged) | Filing History |
| 2022-02-04 09:06 am Sale | 2021-12-31 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Wellington Management Group LLP | 29,320 1.230% | -91,612 (-75.75%) | Filing History |
| 2021-11-02 4:32 pm Sale | 2021-11-01 | 13G | FREELINE THERAPEUTICS HLDGS FRLN | Novo Holdings A/S | 119,038 4.990% | -38,377 (-24.38%) | Filing History |